GSK Licenses Shigella Vaccine to Bharat Biotech
-
GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On
June 12, the company announced licensing its Shigella vaccine candidate to
Bharat...
۵ ساعت قبل
هیچ نظری موجود نیست:
ارسال یک نظر